Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics

Clinical trial NCT07748364 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07748364
Sponsor: Joshua Brody
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory Diffuse Large B-cell Lymphoma Relapsed/Refractory Mantle Cell Lymphoma

Start date: 2026-09-01
Primary completion: 2027-07-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.